Close Menu
healthylife7.comhealthylife7.com

    Subscribe to Updates

    Get the latest creative news from FooBar about art, design and business.

    What's Hot

    Trinity medtech startup NOVAP Medical wins IDEATE 2026; sets sights on tackling ventilator

    August 20, 2026

    Novonesis expects results from weight

    August 20, 2026

    Atour Lifestyle (NASDAQ:ATAT) Announces Quarterly Earnings Results, Beats Expectations By $0.03 EPS

    August 20, 2026
    Facebook X (Twitter) Instagram
    Trending
    • Trinity medtech startup NOVAP Medical wins IDEATE 2026; sets sights on tackling ventilator
    • Novonesis expects results from weight
    • Atour Lifestyle (NASDAQ:ATAT) Announces Quarterly Earnings Results, Beats Expectations By $0.03 EPS
    • Regeneron wins FDA approval to challenge Ipsen for rare bone disease market
    • What Makes a Man Attractive? Research Discovers the Ideal Body
    • Optimize Obesity Development: Endpoint Strategies for Early-phase Innovation to Late-phase Differentiation, Upcoming Webinar Hosted by Xtalks
    • LeBron James, Tyrese Maxey, and Jaylen Brown’s first workout has 76ers fans ready to celebrate
    • The No. 1 Most Important Heart Disease Risk Factor You Can Change, According to a Doctor
    Facebook X (Twitter) Instagram
    healthylife7.comhealthylife7.com
    • Home
    • Fitness
    • Health
    • Nutrition
    • Lifestyle
    • Conditions
    • Mental Health
    • Weight Loss
    • Wellness Tips
    Thursday, August 20
    healthylife7.comhealthylife7.com
    Home»Lifestyle»Atour Lifestyle (NASDAQ:ATAT) Announces Quarterly Earnings Results, Beats Expectations By $0.03 EPS
    Lifestyle

    Atour Lifestyle (NASDAQ:ATAT) Announces Quarterly Earnings Results, Beats Expectations By $0.03 EPS

    healthylife7By healthylife7August 20, 2026No Comments3 Mins Read
    Facebook Twitter Pinterest LinkedIn Tumblr Reddit WhatsApp Email
    Atour Lifestyle (NASDAQ:ATAT) Announces Quarterly Earnings Results, Beats Expectations By $0.03 EPS
    Share
    Facebook Twitter LinkedIn Pinterest WhatsApp Email

    Atour Lifestyle (NASDAQ:ATAT – Get Free Report) announced its earnings results on Thursday. The company reported $0.60 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $0.57 by $0.03, FiscalAI reports. The firm had revenue of $513.74 million during the quarter, compared to analyst estimates of $484.56 million. Atour Lifestyle had a net margin of 17.22% and a return on equity of 51.75%

    Get Atour Lifestyle alerts:

    Atour Lifestyle Price Performance

    • Why Wyndham Hotels Is The Industry Value Play, An Earnings Story

    NASDAQ ATAT opened at $37.00 on Thursday. The company’s fifty day moving average is $33.18 and its two-hundred day moving average is $35.60. Atour Lifestyle has a 52-week low of $30.77 and a 52-week high of $43.17. The firm has a market capitalization of $5.09 billion, a price-to-earnings ratio of 19.89, a P/E/G ratio of 0.97 and a beta of 0.64

    Institutional Investors Weigh In On Atour Lifestyle

    A number of institutional investors have recently added to or reduced their stakes in ATAT. Caitong International Asset Management Co. Ltd lifted its position in Atour Lifestyle by 651.7% during the 3rd quarter. Caitong International Asset Management Co. Ltd now owns 669 shares of the company’s stock worth $25,000 after buying an additional 580 shares in the last quarter. Atlas Capital Advisors Inc. bought a new stake in shares of Atour Lifestyle during the fourth quarter worth approximately $37,000. Mcguire Capital Advisors Inc. bought a new position in Atour Lifestyle in the fourth quarter valued at approximately $49,000. Quarry LP acquired a new stake in Atour Lifestyle during the 3rd quarter worth $66,000. Finally, Smartleaf Asset Management LLC bought a new stake in shares of Atour Lifestyle during the 4th quarter valued at $71,000. 17.79% of the stock is owned by institutional investors and hedge funds.

    Analyst Upgrades and Downgrades

    ATAT has been the subject of several analyst reports. Weiss Ratings reaffirmed a “buy (b-)” rating on shares of Atour Lifestyle in a report on Thursday, August 13th. Zacks Research lowered shares of Atour Lifestyle from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, July 14th. Eight investment analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the stock. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and an average price target of $48.00.

    Ad Porter & Company
    Trump’s New Currency Reset
    Trump is launching a new $250 bill – but that may be a distraction. Behind the scenes, Executive Order 14241 is orchestrating what analyst Porter Stansberry calls a total U.S. money reset, bypassing conventional legal channels under the guise of national security.nnThe last time America reset its currency – under Nixon in the 1970s – it created an average of 1,300 new millionaires a day for over 50 years. Stansberry has identified three asset categories connected to Trump’s initiative that could surge, plus his single top investment move.
    Watch the documentary briefing and find out which side you land on

    Announces Atour lifestyle NASDAQATAT Quarterly
    healthylife7
    • Website

    Related Posts

    WFM ASIA BVI Ltd Buys Shares of 3,131,291 Atour Lifestyle Holdings Limited Sponsored ADR $ATAT

    August 20, 2026

    35 Nuggets of Deer Hunting Wisdom to Read Before the Season

    August 20, 2026

    ATOUR LIFESTYLE ($ATAT) Releases Q2 2026 Earnings

    August 20, 2026
    Leave A Reply Cancel Reply

    Health

    Trinity medtech startup NOVAP Medical wins IDEATE 2026; sets sights on tackling ventilator

    By healthylife7August 20, 20260

    The team are now building a clear pathway towards commercialisation and hope to secure more funding in the near future to test and ultimately bring their innovation into hospitals where it can improve patient care in the coming years

    Novonesis expects results from weight

    August 20, 2026

    Atour Lifestyle (NASDAQ:ATAT) Announces Quarterly Earnings Results, Beats Expectations By $0.03 EPS

    August 20, 2026

    Regeneron wins FDA approval to challenge Ipsen for rare bone disease market

    August 20, 2026
    Stay In Touch
    • Facebook
    • Twitter
    • Pinterest
    • Instagram
    • YouTube
    • Vimeo
    Fitness

    Opinion: The FDA must put biotech at its center or continue to cede early research to China

    July 6, 2026

    Inside Elevance’s digital chronic disease management strategy

    July 6, 2026

    Best, Worst States For Well

    July 6, 2026

    What do the Middle Ages tell us about mental health then and now? VCU historian Leigh Ann Craig has answers

    July 6, 2026

    Subscribe to Updates

    Get the latest creative news from SmartMag about art & design.

    About Us

    Welcome to HealthyLife7.com, your trusted source for reliable health, wellness, fitness, and lifestyle information. Our mission is to help people make informed decisions about their health by providing clear, practical, and easy-to-understand content.

    At HealthyLife7.com, we believe that good health starts with the right knowledge. Whether you're looking for healthy eating tips, fitness advice, mental wellness strategies, weight management guidance, or information about common health conditions, our goal is to deliver valuable content that supports a healthier lifestyle.

    Fitness

    Trinity medtech startup NOVAP Medical wins IDEATE 2026; sets sights on tackling ventilator

    August 20, 2026

    Novonesis expects results from weight

    August 20, 2026

    Atour Lifestyle (NASDAQ:ATAT) Announces Quarterly Earnings Results, Beats Expectations By $0.03 EPS

    August 20, 2026
    Health

    Opinion: The FDA must put biotech at its center or continue to cede early research to China

    July 6, 2026

    Inside Elevance’s digital chronic disease management strategy

    July 6, 2026

    Best, Worst States For Well

    July 6, 2026
    Facebook X (Twitter) Instagram Pinterest
    • About Us
    • Contact us
    • Disclaimer
    • Privacy Policy
    • Terms and Conditions
    © 2026 healthylife7.com. Designed by Pro.

    Type above and press Enter to search. Press Esc to cancel.